Humanised anti-PTHrP antibody
Alternative Names: Anti-PTHrP humanised monoclonal antibody; CALLatest Information Update: 19 Nov 2021
At a glance
- Originator Chugai Pharmaceutical
- Class Monoclonal antibodies
- Mechanism of Action Parathyroid hormone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer metastases; Malignant hypercalcaemia
Most Recent Events
- 06 Feb 2017 Discontinued - Phase-I/II for Malignant hypercalcaemia in Japan (Injection)
- 06 Feb 2017 Discontinued - Phase-II for Cancer metastases in USA (Injection)
- 06 Feb 2017 Discontinued - Phase-II for Malignant hypercalcaemia in USA (IV-injection)